North America to Dominate Over the Counter (OTC) Drugs Market During Forecast Period – TechSci Research

 Growth in awareness related to general health concerns is expected to drive the growth of global over the counter (OTC) drugs market

According to TechSci Research report, “Global Over the Counter (OTC) Drugs Market By Product (Cough, Cold, and Flu, Analgesics, Dermatology Products, Vitamins, Mineral, and Supplements (VMS), Other), By Dosage Form (Tablets, Capsules, Powders, Ointments, Liquids), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Other), By Region, Forecast & Opportunities, 2025”, Global Over the Counter (OTC) drugs market exceeded USD 140 billion in 2019 and is expected to witness a significant CAGR of around 8.23% during the forecast period. Growing inclination of pharmaceutical companies toward OTC drugs from Rx drugs is one of the major factors accounting for the growth of global over the counter (OTC) drugs market. Moreover, favorable regulatory framework is expected to bode well for the growth of global over the counter (OTC) drugs market through the forecast period. In addition to this, increasing product innovations is expected to positively influence the growth of global over the counter (OTC) drugs market in the years to come. Also, surging trend among the individuals to select OTC drugs for minor diseases is making headway for the growth of global over the counter (OTC) drugs market. Along with this, supportive government funding is positively contributing to the market growth. Also, rising tendency of people towards self-medication in developing economies is expected to bolster the market growth in the coming years. Furthermore, the key market players are switching from Rx to OTC on account of increasing patent expiration rates which is aiding the market growth. Also, the OTC drugs usage are economically beneficial which is accredited to savings on drug cost coupled with cost incurred on clinical visit, due to which, the global over the counter (OTC) drugs market is projected to rev up in the next 5 years. However, there are certain factors that might act as major impediments to the growth of global over the counter (OTC) drugs market during the forecast period such as stringent regulations by the FDA related to the safety and efficacy of OTC drugs.

Browse 142 Figures spread through 110 Pages and an in-depth TOC on " Global Over the Counter (OTC) Drugs Market "

 

https://www.techsciresearch.com/report/over-the-counter-drugs-market/5054.html

 

Global over the counter (OTC) drugs market can be segmented based on product, dosage form, distribution channel, and region. Considering the dosage form, the market is fragmented into tablets, capsules, powders, ointments, liquids. Among these, the tablets segment dominated the global over the counter (OTC) drugs market in terms of largest market share until 2019 and is further anticipated to maintain its dominance during the forecast period as well. This can be ascribed to their longer shelf life coupled with its cost-effective manufacturing process. Additionally, they can accommodate a higher dose of active ingredient as compared to capsules, which is further boosting the segmental growth.

Johnson and Johnson, GlaxoSmithKline PLC (GSK Consumer Healthcare), Perrigo Company PLC, Reckitt Benckiser Group PLC, Takeda Pharmaceutical Company Ltd, Roche Holding AG, The Procter & Gamble Company, Sanofi S.A, Gilead Sciences Inc., Bayer Healthcare AG, AstraZeneca plc., Alacer Corp., Alcon Inc., and others are the leading players operating in global over the counter (OTC) drugs market. The players are adopting several growth strategies to enhance the market scenario of over the counter (OTC) drugs. Other competitive strategies include product launches, acquiring each other’s OTC business division mergers & acquisitions, agreements, partnerships, and collaborations, and expansions to diverse their product portfolio in order to strengthen their market position.

download sample report @ https://www.techsciresearch.com/sample-report.aspx?cid=5054

customers can also request for 10% free customization on this report.

“North America is expected to dominate the global over the counter (OTC) drugs market until 2025 on account of growing awareness pertaining to personal care and treatment in the region. Furthermore, increasing R&D in healthcare industries is also contributing to the growing trend. On the other hand, Asia-Pacific region is anticipated to register highest CAGR over the years to come, which can be attributed to rising investment by the government to develop health care industries in the region. In addition to this, growing middle class population along with increase in disposable income is further expected to bolster the growth of global over the counter (OTC) drugs market in the region.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Global Over the Counter (OTC) Drugs Market By Product (Cough, Cold, and Flu, Analgesics, Dermatology Products, Vitamins, Mineral, and Supplements (VMS), Other), By Dosage Form (Tablets, Capsules, Powders, Ointments, Liquids), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Other), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of global over the counter (OTC) drugs market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global over the counter (OTC) drugs market.

Browse Related Reports

Global Oncology Drugs Market By Drug Type (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs), By Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others), By Drug Therapy (Adjuvant, Neoadjuvant and Concurrent), By Route of Administration (Oral, Intravenous, Subcutaneous, Others), By Gender (Male, Female), By Cancer Type (Lung Cancer, Stomach Cancer, Others), By Distribution Channel (Hospital Pharmacies, Others), By Region, Competition, Forecast & Opportunities, 2025

 https://www.techsciresearch.com/report/oncology-drugs-market/4689.html    

 

 Global Consumer Healthcare Market By Product (Over-the-Counter Drugs (OTC); Vitamins and Dietary Supplements; Herbal/Traditional Products; Sports Nutrition; and Others), By Distribution Channel (Modern Grocery Retail; Traditional Grocery Retail; Non-Grocery/Mixed Retailers; Non-store-based Retail; and Others), By Region, Forecast & Opportunities, 2025

 

https://www.techsciresearch.com/report/consumer-healthcare-market/4680.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

 Tel: +1-646-360-1656

 Email: sales@techsciresearch.com

website : https://www.techsciresearch.com

PCOS Treatment Market to Witness Significant Growth until 2025 – TechSci Research

 Rising obesity among women population to drive the growth of global PCOS treatment market

According to TechSci Research report, “Global PCOS Treatment Market By Surgery (Ovarian Wedge Resection, Cyst Aspiration, Laparoscopic Ovarian Drilling), By Drug (Ovulation Inducing Agents, Insulin-Sensitizing Agents, Oral Contraceptives, Antiandrogens, Anti-Depressants, Insulin-Sensitizing Agents, Anti-Obesity Drugs, Others), By Diagnosis (Pelvic Examination, Ultrasound, Blood Tests), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility Clinics), By Region, Forecast & Opportunities, 2025”, the global PCOS treatment market is expected to grow at a formidable rate of around 8.63% during the forecast period on account of the rising awareness pertaining to diseases and reproductive health among the population. Additionally, initiatives taken by various government and non-government organizations for spreading awareness and providing schemes and services for the welfare of women is further expected to positively impact the growth of market over the next few years. Furthermore, easy access to PCOS therapeutics, growing demand for PCOS medication and rising popularity of combination therapy are further expected to foster the growth of market through 2025. However, easy availability of generics and off the label drugs might hinder the growth of market during forecast period. Additionally, lack of approved therapeutics and side effects of the available drugs might hamper the growth of market over the next few years. Also, at present no targeted therapy is available for this syndrome & it is only controlled through medication and some surgical procedures.

Browse 1  market data Tables and 37 Figures spread through 110 Pages and an in-depth TOC on " Global PCOS Treatment Market"

https://www.techsciresearch.com/report/pcos-treatment-market/4683.html

 

The global PCOS treatment market is segmented based on surgery, drug, diagnosis, end user, company and region. The drug the market can be categorized into ovulation inducing agents, oral contraceptives, antiandrogens, anti-depressants, insulin-sensitizing agents, anti-obesity drugs, others. The oral contraceptive drugs are expected to register the fastest growth through the forecast period owing to their widespread use as first line of treatment for PCOS. These contraceptives help in regulating the menstruation cycles in the patient. Additionally, these are helpful in treating severe menstrual pain, Premenstrual syndrome (PMS), and acne, which are common symptoms of Polycystic ovary syndrome.

Bristol-Myers Squibb Company, Bayer AG, Pfizer, Inc., Abbott Laboratories, Inc., Merck & Co., Inc., Sanofi SA, AstraZeneca Plc, Novartis AG, Teva Pharmaceutical Industries Limited, Ferring Pharmaceuticals, Inc., and others are some of the leading players operating in global PCOS treatment market. The companies operating in the market are using organic strategies such as product launches, mergers and collaborations to boost their share. For instance, in January 2106, AstraZeneca announced that they have started start up for women health treatment and invested USD 62 million in drug development for poly cystic ovarian disorder.

Download Sample Report  @ https://www.techsciresearch.com/sample-report.aspx?cid=4683

Customers can also request for 10% free customization on this report.

“North America is expected to dominate the global PCOS treatment market during the forecast period, owing to the presence of well-developed healthcare infrastructure in the region. Additionally, availability of skilled medical personnel coupled with large PCOS patient pool especially in the United States is further expected to create lucrative opportunities for the market players over the next few years.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

 

“Global PCOS Treatment Market By Surgery (Ovarian Wedge Resection, Cyst Aspiration, Laparoscopic Ovarian Drilling), By Drug (Ovulation Inducing Agents, Insulin-Sensitizing Agents, Oral Contraceptives, Antiandrogens, Anti-Depressants, Insulin-Sensitizing Agents, Anti-Obesity Drugs, Others), By Diagnosis (Pelvic Examination, Ultrasound, Blood Tests), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility Clinics), By Region, Forecast & Opportunities, 2025”,” has evaluated the future growth potential of global PCOS treatment market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global PCOS treatment market.

Browse Related Reports

Global Clinical Diagnostics Market By Type of Test (Lipid Panel, Metabolic Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, Others), By Product (Instruments, Reagents, Software & Services), By Application (Infectious Diseases (Sepsis, Respiratory Diseases, Gastrointestinal Diseases, Nephrological Diseases, New Corona Virus (COVID-19), AIDS & Hepatitis), Antimicrobial Resistance & Health Associated Infections (Antimicrobial Resistance, HAIs, Others), Cardiovascular Emergencies, Personalized Medicine, Others(Industrial Applications (Agri-food sector, Biopharma, Cosmetics)), By End User (Hospital, Diagnostic Laboratory, Point-of-Care Testing, Academic & Medical Schools, Others), By Region, Forecast & Opportunities, 2025

https://www.techsciresearch.com/report/clinical-diagnostics-market/4519.html

Global Leukemia Therapeutics Market By Factor (Artificial ionizing radiation, Viruses, Others), By Severity (Acute, Chronic), By Blood Cell (Lymphocytic, Myelogenous), By Age Groups (0-15, 15-30, 30-50, 50+), By Sex (Male, Female), By Treatment (Targeted Therapy, Interferon Therapy, Radiation Therapy, Others), By Diagnosis (Blood test, Biopsy, Physical Exam, Imagining), By Route of Administration (Oral, Intravenous, Subcutaneous, Intramuscular, Intrathecal), By Drugs (Antimetabolites, Biosimilars, Others), By Region, Forecast & Opportunities, 2025

https://www.techsciresearch.com/report/leukemia-therapeutics-market/4534.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com

website : https://www.techsciresearch.com

North America to Lead Global Medical Imaging Monitor Market during the Forecast Period - TechSci Research

 Growing number of medical establishments across the globe are expected to drive medical imaging monitor market through 2025.

According to TechSci Research report, “Global Medical Imaging Monitor Market By Device, By Panel Size, By Type, By Display Color, By Purpose, By Technology, By Application, By Modality, By Resolution, By Grade, By Region, Competition, Forecast & Opportunities, 2025”, Global medical imaging monitor market was valued at USD 2.07 billion in 2019 by witnessing a growing CAGR of around 10% to reach USD 3.06 billion in 2025 on account of increasing geriatric population suffering from various chronic diseases such as cancer, diabetes, cardiovascular disorders, renal disorders, among others. This has drastically increased the patient pool and the need to effectively diagnose and treat these diseases, which in turn is expected to drive the market during forecast period. Additionally, increasing adoption of hybrid operating room technologies is further expected to create lucrative growth opportunities over the next few years. Growing adoption of minimal invasive treatment procedures is anticipated to fuel the market through 2025.

Advantages such as high quality of screen, clear and consistent images, accurate analysis, reliability, short replacement cycle, among others associated with medical imaging monitors are further expected to spur the market in the coming years. Besides, increasing investment in the medical imaging devices by the key players operating in the market is further expected to bolster the growth through 2025. However, high cost and maintenance of medical imaging monitors might hamper the growth during forecast period. Additionally, growing adoption of refurbished medical imaging monitors might further negatively impact the market over the course of next five years.

Browse 318 market data Figures & Tables spread through 316 Pages and an in-depth TOC on

"Global Medical Imaging Monitor Market"

https://www.techsciresearch.com/report/medical-imaging-monitor-market/4696.html

The global medical imaging monitor market is segmented based on device, panel size, type, display color, purpose, technology, application, modality, resolution, grade, company and region. Based on device, the market can be categorized into mobile, desktop and all-in-one. The desktop segment is expected to dominate the market with a share of around 65% in 2019 on account of their high and increasing adoption in several imaging applications such as X-ray, CT-Scan, ultrasound, MRI, among others. Based on panel size, the market can be fragmented into under-22.9-inch panels, 23.0–26.9-inch panels, 27.0–41.9-inch panels and above-42-inch panels. The 27.0–41.9-inch panels segment dominated the market until 2019 owing to their suitability for a wider range of surgical and diagnostic applications. On the other hand, the 23.0–26.9-inch panels are projected to register highest growth in years to come owing to their medium size resulting in increased clarity and more effective visualization of medical image.

Based on type, the market can be grouped into diagnostic monitors, surgical monitors, clinical monitors and others. The diagnostic display monitor segment is expected to hold the largest market share through 2025 on account of their growing adoption in various imaging applications such as X-ray, MRI, CT-Scan, among others. Based on display color, the market can be bifurcated into monochrome and colored. The colored display segment is expected to dominate the market over next few years. This can be attributed to their widespread use for carrying out diagnostic and surgical procedures since they offer better visualization effects. Based on technology, the market can be segmented into LED-Backlit LCD, OLED and CCFL-Backlit LCD. The LED-Backlit LCD dominated the market until 2019 and is expected to remain the largest technology segment during the forecast period as well since these monitors are compact in size, offer more brightness, have better contrast ratio as compared to the counterparts. Additionally, these are easily available, affordable and are the first choice of the consumers.

Download Sample Report  @ https://www.techsciresearch.com/sample-report.aspx?cid=4696

Customers can also request for 10% free customization on this report.

Siemens Healthineers AG, Advantech Co Ltd, Steris Corporation, Jvckenwood Corporation, Canon Inc., FSN Medical Technologies, Novanta Inc., EIZO Corporation, Barco NV, Alpha Display Co. Ltd., LG Display Co., Ltd, Sony Corporation, BenQ Medical Technology Corporation, Nanjing Jusha Commercial &Trading Co, Ltd, Hisense Medical, COJE Co., Ltd., Shenzhen Beacon Display Technology Co., Ltd., Dell Technologies Inc., Quest International, Inc., Double Black Imaging Corporation, Axiomtek Co., Ltd are some of the leading players operating in the global medical imaging monitor market.

“North America is expected to dominate the medical imaging monitor market during the forecast period owing to the growing initiatives by the U.S. government towards early diagnosis and to increase the count of medical imaging procedures. Additionally, presence of a large number of hospitals with advanced healthcare infrastructure is expected to propel the market in the coming years. Rising preference for minimal invasive surgeries among the population is further expected to positively impact the region’s medical imaging monitor market through 2025.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Global Medical Imaging Monitor Market By Device, By Panel Size, By Type, By Display Color, By Purpose, By Technology, By Application, By Modality, By Resolution, By Grade, By Region, Competition, Forecast & Opportunities, 2025”, has evaluated the future growth potential of global medical imaging monitor market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global medical imaging monitor market.

Browse Related Reports

Global Portable Ventilator Market, By Type (Invasive Ventilation, Non-Invasive Ventilation), By Mode (Pressure Mode Ventilation; Volume Mode Ventilation; Combined Mode Ventilation), By Application (Aeromedical; Pediatrics; Domiciliary Ventilation; Non-Invasive Ventilation), By End User (Hospital; Ambulance; Clinic; Rehabilitation Center; Others), By Region, Forecast & Opportunities, 2025

https://www.techsciresearch.com/report/portable-ventilator-market/4541.html

Global Electrosurgery Devices Market By Product (Electrosurgical Generators (Radiofrequency, Ultrasonic, Argon Plasma, Cryoablation, Microwave, Combination and Smoke Evacuators), Electrosurgical Instruments (Electrosurgical Electrodes (Monopolar, Bipolar), Pencils (Monopolar, Bipolar), Forceps, Cryoprobes, Nano knifes and Others)), Accessories), By Application (Orthopedics, Oncology, Cardiovascular, General, Cosmetic, Neurology and Others), By End-user (Hospitals, Ambulatory Surgical Centers and Others), By Region, Forecast & Opportunities, 2025

https://www.techsciresearch.com/report/electrosurgery-devices-market/4589.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

 Tel: +1-646-360-1656

 Email: sales@techsciresearch.com

website : https://www.techsciresearch.com